These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36828640)

  • 1. Fibroblast growth factor 23 in children with or without heart failure: a prospective study.
    Elzayat RS; Bahbah WA; Elzaiat RS; Elgazzar BA
    BMJ Paediatr Open; 2023 Feb; 7(1):. PubMed ID: 36828640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.
    Isakova T; Houston J; Santacruz L; Schiavenato E; Somarriba G; Harmon WG; Lipshultz SE; Miller TL; Rusconi PG
    Pediatr Nephrol; 2013 Oct; 28(10):2035-42. PubMed ID: 23740037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure.
    Vergaro G; Aimo A; Taurino E; Del Franco A; Fabiani I; Prontera C; Masotti S; Musetti V; Emdin M; Passino C
    Int J Cardiol; 2021 Aug; 336():98-104. PubMed ID: 34019969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Lyngbakken MN; Pervez MO; Brynildsen J; Pedersen MH; Sølvernes J; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2018 Feb; 52():41-47. PubMed ID: 29074091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
    Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE
    Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
    Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
    ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction.
    Vergaro G; Del Franco A; Aimo A; Gentile F; Castiglione V; Saponaro F; Masotti S; Prontera C; Fusari N; Emdin M; Passino C
    BMC Cardiovasc Disord; 2023 Sep; 23(1):433. PubMed ID: 37658340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
    Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V
    Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure.
    Andersen IA; Huntley BK; Sandberg SS; Heublein DM; Burnett JC
    Nephrol Dial Transplant; 2016 May; 31(5):767-72. PubMed ID: 26666498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases.
    Chowdhury RR; Kaur S; Gera R
    Pediatr Cardiol; 2023 Dec; 44(8):1716-1720. PubMed ID: 37563318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure.
    Tsai JP; Sung KT; Su CH; Lai YH; Kuo JY; Yun CH; Yen CH; Hou CJ; Wu TH; Peng MC; Hung TC; Yeh HI; Hung CL
    ESC Heart Fail; 2019 Aug; 6(4):723-732. PubMed ID: 30993903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.